We are live on ! Find out more
NERV icon

Minerva Neurosciences
NERV

19 hedge funds and large institutions have $19M invested in Minerva Neurosciences in 2023 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 8 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

609% more capital invested

Capital invested by funds: $2.69M → $19M (+$16.4M)

300% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 2

200% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 1

12% more funds holding

Funds holding: 17 → 19 (+2)

10.75% more ownership

Funds ownership: 31.48% → 42.23% (+11%)

Holders
19
Holders Change
+2
Holders Change %
+11.76%
% of All Funds
0.3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
8
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$2.6M
2
Federated Hermes
Federated Hermes
Pennsylvania
+$792K
3
VF
Virtu Financial
New York
+$111K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$59.2K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$57.6K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$66K
2
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$36.3K
3
BAM
Belpointe Asset Management
Nevada
-$160
Name Holding Trade Value Shares
Change 		Change in
Stake
Federated Hermes
1
Federated Hermes
Pennsylvania
$9.9M +$792K +150,000 +12%
Fidelity Investments
2
Fidelity Investments
Massachusetts
$4.49M +$2.6M +491,746 New
Vanguard Group
3
Vanguard Group
Pennsylvania
$1.88M +$59.2K +11,216 +6%
Renaissance Technologies
4
Renaissance Technologies
New York
$898K -$66K -12,500 -11%
BlackRock
5
BlackRock
New York
$721K – – –
Geode Capital Management
6
Geode Capital Management
Massachusetts
$475K +$57.6K +10,900 +27%
Acadian Asset Management
7
Acadian Asset Management
Massachusetts
$195K -$36.3K -6,878 -24%
VF
8
Virtu Financial
New York
$192K +$111K +20,993 New
State Street
9
State Street
Massachusetts
$125K – – –
Morgan Stanley
10
Morgan Stanley
New York
$82.2K +$2.22K +420 +5%
JP Morgan Chase
11
JP Morgan Chase
New York
$41.3K +$23.8K +4,514 +150,467%
Wells Fargo
12
Wells Fargo
California
$18.1K +$5 +1 +0.1%
TRCT
13
Tower Research Capital (TRC)
New York
$11.5K +$2.28K +432 +53%
Russell Investments Group
14
Russell Investments Group
United Kingdom
$10.7K – – –
UBS Group
15
UBS Group
Switzerland
$3.97K +$2.29K +434 New
Royal Bank of Canada
16
Royal Bank of Canada
Ontario, Canada
$2K +$222 +42 +24%
TFM
17
TFC Financial Management
Massachusetts
$1.7K – – –
Northwestern Mutual Wealth Management
18
Northwestern Mutual Wealth Management
Wisconsin
$914 – – –
AIM
19
Anchor Investment Management
South Carolina
$110 – – –
BAM
20
Belpointe Asset Management
Nevada
– -$160 -100 Closed

NERV Hedge Fund Activity: Q2 2023 in Review

19 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Minerva Neurosciences (NERV) for Q2 2023, worth a combined $19M — up 609% from $2.69M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new NERV positions and 1 closed out — a net gain of 2 holders — while 8 added to existing stakes and 2 trimmed.

The largest buyer was Fidelity Investments, opening a new position worth an estimated $2.6M. The largest seller was Renaissance Technologies, cutting an estimated $66K.

  • 19 institutional investors held Minerva Neurosciences (NERV) as of Q2 2023, up from 17 in Q1 2023.
  • Funds reported $19M of Minerva Neurosciences stock for Q2 2023, up 609% quarter-over-quarter.
  • 3 funds opened new Minerva Neurosciences positions in Q2 2023 and 1 closed out, a net change of +2 holders.
  • The largest Minerva Neurosciences buyer in Q2 2023 was Fidelity Investments, an estimated $2.6M added.
  • The largest Minerva Neurosciences seller in Q2 2023 was Renaissance Technologies, an estimated $66K sold.

Based on aggregated 13F filings for Q2 2023.